Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: a Real-world Analysis of VTE Risk and the Impact of VTE on Healthcare Expenditure

被引：0
|
作者：
Lyman, G. H. [1 ]
Wang, Y. [2 ]
Wang, H. [3 ]
Cohen, A. T. [4 ]
机构：
[1] Duke Univ, Durham, NC 27706 USA
[2] ETeam Inc, Bridgewater, MA USA
[3] Sanofi Aventis, R&D, Bridgewater, MA USA
[4] Kings Coll Hosp, Dept Surg & Vasc Med, London, England
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)71075-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S222 / S222
页数：1
相关论文
共 50 条
  • [1] Heparin use and venous thromboembolism (VTE) among cancer patients receiving chemotherapy with a prior history of VTE
    Cherkowski, G.
    Dietrich, J.
    Chen, F.
    Fryzek, J.
    Bridges, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Evaluation of venous thromboembolism (VTE) risk among ambulatory patients with pancreatic cancer in a real-world setting
    Lin, Jay
    Dalal, Mehul R.
    Connolly, Gregory Clayton
    Khorana, Alok A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Venous thromboembolism (VTE) risk assessment in cancer patients receiving chemotherapy in a tertiary care center
    Varghese, Smita
    Pai, Radhika R.
    DSouza, Janet Prameela
    Badagabettu, Sulochana
    Udupa, Karthik S.
    Pai, Anantha
    [J]. JOURNAL OF VASCULAR NURSING, 2022, 40 (04) : 167 - 171
  • [4] ANALYSIS OF VENOUS THROMBOEMBOLISM (VTE) AMONG PATIENTS WITH CANCER FROM REAL-WORLD FRENCH ADMINISTRATIVE DATABASE
    Couturaud, F.
    Saighi, A.
    Barreau, M.
    Sedjelmaci, F.
    Lafon, T.
    Gleize, J. C.
    Schmidt, A.
    Mismetti, P.
    [J]. VALUE IN HEALTH, 2020, 23 : S498 - S498
  • [5] Bleeding Risk in Thrombocytopenic Cancer Patients with Venous Thromboembolism (VTE) Receiving Anticoagulation
    Pemmaraju, Naresh
    Kroll, Michael H.
    Afshar-Kharghan, Vahid
    Oo, Thein H.
    [J]. BLOOD, 2012, 120 (21)
  • [6] Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk
    Liebman, Howard A.
    [J]. THROMBOSIS RESEARCH, 2018, 164 : S19 - S22
  • [7] Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients
    Gauthier, K.
    Kovacs, M. J.
    Wells, P. S.
    Le Gal, G.
    Rodger, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) : 200 - 203
  • [8] VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH PANCREATIC CANCER
    Kim, K. H.
    Yoon, S. Y.
    Yoon, J.
    Kim, H. J.
    Kim, S. H.
    Kim, H. J.
    Lee, S. C.
    Bae, S. B.
    Kim, C. K.
    Lee, N.
    Park, S. K.
    Won, J. H.
    Hong, D. S.
    Park, H. S.
    [J]. HAEMATOLOGICA, 2014, 99 : 780 - 781
  • [9] Venous Thromboembolism (VTE) In Patients With Pancreatic Cancer
    Kim, Kyoung Ha
    Yoon, Seug Yun
    Yoon, Jina
    Kim, Han Jo
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan-Kyu
    Lee, Namsu
    Park, Sung Kyu
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hee Sook
    [J]. BLOOD, 2013, 122 (21)
  • [10] Venous thromboembolism (VTE) risk stratification in hospitalized cancer patients
    Hijjawi, S. B.
    Jallad, S. G.
    Ababneh, B. A.
    Abdel-Razeq, H. N.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 797 - 797
12345